ARCHIVES

NCI Signs Letters Of Intent With Latin American Countries

This article is from The Cancer Letter archive.

Vol. 35 No. 36 | October 2, 2009

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

June 28, 2002

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Hamburg Confirmed As FDA Commissioner

May 22, 2009